Free Trial

Amneal Pharmaceuticals (AMRX) Insider Trading & Ownership

Amneal Pharmaceuticals logo
$8.47 +0.06 (+0.71%)
(As of 09:48 AM ET)

Amneal Pharmaceuticals (NASDAQ:AMRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
26.56%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$375,886.77
Get AMRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Amneal Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AMRX Insider Buying and Selling by Quarter

Amneal Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/15/2024Jason B DalySVPSell43,657$8.61$375,886.77  
(Data available from 1/1/2013 forward)

AMRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Amneal Pharmaceuticals includes Andrew S Boyer, Chirag K Patel, Gautam Patel, Jason B Daly, Joseph Todisco, Nikita Shah, and Tpg Gp A, Llc. Learn more on insiders at AMRX.

26.56% of Amneal Pharmaceuticals stock is owned by insiders. Learn more on AMRX's insider holdings.

The following insiders have sold AMRX shares in the last 24 months: Andrew S Boyer ($121,017.26), Jason B Daly ($375,886.77), and Tpg Gp A, Llc ($9,089,964.00).

Insiders have sold a total of 3,957,559 Amneal Pharmaceuticals shares in the last 24 months for a total of $9,586,868.03 sold.

Amneal Pharmaceuticals Key Executives



This page (NASDAQ:AMRX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners